b. Perform a hypothesis test to test whether the proportion of patients who achieve a positive outcome with the current treatment (ritonavir-boosted darunavir) is less than the pro positive outcome with the new treatment (dorovirine). Use a significance level of 0.01. Analyze the results and determine if dorovirine is a more effective treatment for HIV-1 than Consider population 1 to be the ritonavir-boosted darunavir with the proportion of positive outcomes p, and population 2 to be the dorovirine with the proportion of positive outco alternative hypotheses for the hypothesis test? O A. Ho: P1 = P2 Ha: P1 P2 OC. Ho: P1 =P2 Ha: P1 # P2 O D. Ho: P1 > P2 Ha: P1 = P2 O E. Ho: P1 * P2 Ha: P1 = P2 OF. Ho: P1
b. Perform a hypothesis test to test whether the proportion of patients who achieve a positive outcome with the current treatment (ritonavir-boosted darunavir) is less than the pro positive outcome with the new treatment (dorovirine). Use a significance level of 0.01. Analyze the results and determine if dorovirine is a more effective treatment for HIV-1 than Consider population 1 to be the ritonavir-boosted darunavir with the proportion of positive outcomes p, and population 2 to be the dorovirine with the proportion of positive outco alternative hypotheses for the hypothesis test? O A. Ho: P1 = P2 Ha: P1 P2 OC. Ho: P1 =P2 Ha: P1 # P2 O D. Ho: P1 > P2 Ha: P1 = P2 O E. Ho: P1 * P2 Ha: P1 = P2 OF. Ho: P1
MATLAB: An Introduction with Applications
6th Edition
ISBN:9781119256830
Author:Amos Gilat
Publisher:Amos Gilat
Chapter1: Starting With Matlab
Section: Chapter Questions
Problem 1P
Related questions
Topic Video
Question
100%
Can someone please explain these for me? I’m very confused.
![(Round to two decimal places as needed.)
b. Perform a hypothesis test to test whether the proportion of patients who achieve a positive outcome with the current treatment (ritonavir-boosted darunavir) is less than the pro
positive outcome with the new treatment (dorovirine). Use a significance level of 0.01. Analyze the results and determine if dorovirine is a more effective treatment for HIV-1 than
Consider population 1 to be the ritonavir-boosted darunavir with the proportion of positive outcomes p, and population 2 to be the dorovirine with the proportion of positive outco
alternative hypotheses for the hypothesis test?
O A. Ho: P1 = P2
Ha: P1 <P2
O D. Ho: P1 > P2
Ha: P1 = P2
O B. Ho: P1 = P2
Ha: P1 > P2
O E. Ho: P1 # P2
OC. Ho: P1 = P2
Ha: P1 #P2
OF. Ho: P1 <P2
Hg: P1 =P2
Ha: P1 = P2
Identify the test statistic.
z=
(Round to two decimal places as needed.)
Identify the p-value.
p-value =
(Round to three décimal places as needed.)
Since the p-value is (1)
the significance level of a = 0.01, (2)
the null hypothesis. There is (3).
evidence to support the clai
ritonavir-boosted darunavir group is (4)
the percentage from the dorovirine group.
Analyze the results. Is dorovirine a more effective treatment for HIV-1 than ritonavir-boosted darunavir? Why or why not?
O A. Yes, since the decision of the test was to fail to reject the null hypothesis of the proportion from the ritonavir-boosted darunavir group being greater than the proporti
O B. No, since the decision of the test was to fail to reject the null hypothesis of no difference.
O C. No; although the decision of the test was to reject the null hypothesis of no difference, it cannot be concluded that one treatment is better than the other-it can on
O D. Yes, since the decision of the test was to reject the null hypothesis of no difference.
(1) O greater than
O less than
O reject
O fail to reject
(2)
(3) O insufficient
O sufficient
(4) O greater than
O different from
O. less than
MacBook Pro](/v2/_next/image?url=https%3A%2F%2Fcontent.bartleby.com%2Fqna-images%2Fquestion%2F024feced-9bfd-4b89-b912-3fa08955cb1a%2F2e212986-3033-460f-974a-6cd7f24a9e1b%2Fboa7mmft_processed.jpeg&w=3840&q=75)
Transcribed Image Text:(Round to two decimal places as needed.)
b. Perform a hypothesis test to test whether the proportion of patients who achieve a positive outcome with the current treatment (ritonavir-boosted darunavir) is less than the pro
positive outcome with the new treatment (dorovirine). Use a significance level of 0.01. Analyze the results and determine if dorovirine is a more effective treatment for HIV-1 than
Consider population 1 to be the ritonavir-boosted darunavir with the proportion of positive outcomes p, and population 2 to be the dorovirine with the proportion of positive outco
alternative hypotheses for the hypothesis test?
O A. Ho: P1 = P2
Ha: P1 <P2
O D. Ho: P1 > P2
Ha: P1 = P2
O B. Ho: P1 = P2
Ha: P1 > P2
O E. Ho: P1 # P2
OC. Ho: P1 = P2
Ha: P1 #P2
OF. Ho: P1 <P2
Hg: P1 =P2
Ha: P1 = P2
Identify the test statistic.
z=
(Round to two decimal places as needed.)
Identify the p-value.
p-value =
(Round to three décimal places as needed.)
Since the p-value is (1)
the significance level of a = 0.01, (2)
the null hypothesis. There is (3).
evidence to support the clai
ritonavir-boosted darunavir group is (4)
the percentage from the dorovirine group.
Analyze the results. Is dorovirine a more effective treatment for HIV-1 than ritonavir-boosted darunavir? Why or why not?
O A. Yes, since the decision of the test was to fail to reject the null hypothesis of the proportion from the ritonavir-boosted darunavir group being greater than the proporti
O B. No, since the decision of the test was to fail to reject the null hypothesis of no difference.
O C. No; although the decision of the test was to reject the null hypothesis of no difference, it cannot be concluded that one treatment is better than the other-it can on
O D. Yes, since the decision of the test was to reject the null hypothesis of no difference.
(1) O greater than
O less than
O reject
O fail to reject
(2)
(3) O insufficient
O sufficient
(4) O greater than
O different from
O. less than
MacBook Pro
![Print
40. A study for the treatment of patients with HIV-1 was a randomized, controlled, double-blind study that compared the effectiveness of ritonavir-boosted darunavir (rbd), the drug currently used to treat HIV-1, with
dorovirine, a newly developed drug. Of the 384 subjects taking ritonavir-boosted darunavir, 309 achieved a positive result. Of the 384 subjects taking dorovirine, 325 achieved a positive result. Complete parts (a) and
(b).
a. Find the sample percentage of subjects who achieved a positive outcome in each group.
The sample percentage of subjects who achieve a positive outcome with ritonavir-boosted darunavir is
%. The sample percentage of subjects who achieve a positive outcome with dorovirine is
%.
(Round to two decimal places as needed.)
b. Perform a hypothesis test to test whether the proportion of patients who achieve a positive outcome with the current treatment (ritonavir-boosted darunavir) is less than the proportion of patients who achieve a
positive outcome with the new treatment (dorovirine). Use a significance level of 0.01. Analyze the results and determine if dorovirine is a more effective treatment for HIV-1 than ritonavir-boosted darunavir,
Consider population 1 to be the ritonavir-boosted darunavir with the proportion of positive outcomes p, and population 2 to be the dorovirine with the proportion of positive outcomes p2. What are the null and
alternative hypotheses for the hypothesis test?
O A. Ho: P1 = P2
Ha: P1 <P2
O B. Ho: P1 = P2
H: P, > P2
OC. Ho: P1 = P2
Ha: P1 #P2
O D. Ho: P1 > P2
Ha: P1 = P2
O E. Ho: P1 * P2
Hạ: P1 =P2
OF. Ho: P1 <P2
Ha: P1 =P2
Identify the test statistic.
(Round to two decimal places as needed.)
Identify the p-value.
p-value =
(Round to three decimal places as needed.)
Since the p-value is (1)
the significance level of a = 0.01, (2)
the null hypothesis. There is (3)
evidence to support the claim that the percentage from the
ritonavir-boosted darunavir group is (4).
the percentage from the dorovirine group.
Analyze the results. Is dorovirine a more effective treatment for HIV-1 than ritonavir-boosted darunavir? Why or why not?
O A. Yes, since the decision of the test was to fail to reject the null hypothesis of the proportion from the ritonavir-boosted darunavir group being greater than the proportion of the dorovirine group.
O B. No, since the decision of the test was to fail to reject the null hypothesis of no difference.
OC. No; although the decision of the test was to reject the null hypothesis of no difference, it cannot be concluded that one treatment is better than the other-it can only be concluded that they are different.
O D. Yes, since the decision of the test was to reject the null hypothesis of no difference.
MacBook Pro
esc
G Search or type URL
@
#3
2$
%
&
2
3
4
7
8
9.
dele
LO](/v2/_next/image?url=https%3A%2F%2Fcontent.bartleby.com%2Fqna-images%2Fquestion%2F024feced-9bfd-4b89-b912-3fa08955cb1a%2F2e212986-3033-460f-974a-6cd7f24a9e1b%2F4lp4vd_processed.jpeg&w=3840&q=75)
Transcribed Image Text:Print
40. A study for the treatment of patients with HIV-1 was a randomized, controlled, double-blind study that compared the effectiveness of ritonavir-boosted darunavir (rbd), the drug currently used to treat HIV-1, with
dorovirine, a newly developed drug. Of the 384 subjects taking ritonavir-boosted darunavir, 309 achieved a positive result. Of the 384 subjects taking dorovirine, 325 achieved a positive result. Complete parts (a) and
(b).
a. Find the sample percentage of subjects who achieved a positive outcome in each group.
The sample percentage of subjects who achieve a positive outcome with ritonavir-boosted darunavir is
%. The sample percentage of subjects who achieve a positive outcome with dorovirine is
%.
(Round to two decimal places as needed.)
b. Perform a hypothesis test to test whether the proportion of patients who achieve a positive outcome with the current treatment (ritonavir-boosted darunavir) is less than the proportion of patients who achieve a
positive outcome with the new treatment (dorovirine). Use a significance level of 0.01. Analyze the results and determine if dorovirine is a more effective treatment for HIV-1 than ritonavir-boosted darunavir,
Consider population 1 to be the ritonavir-boosted darunavir with the proportion of positive outcomes p, and population 2 to be the dorovirine with the proportion of positive outcomes p2. What are the null and
alternative hypotheses for the hypothesis test?
O A. Ho: P1 = P2
Ha: P1 <P2
O B. Ho: P1 = P2
H: P, > P2
OC. Ho: P1 = P2
Ha: P1 #P2
O D. Ho: P1 > P2
Ha: P1 = P2
O E. Ho: P1 * P2
Hạ: P1 =P2
OF. Ho: P1 <P2
Ha: P1 =P2
Identify the test statistic.
(Round to two decimal places as needed.)
Identify the p-value.
p-value =
(Round to three decimal places as needed.)
Since the p-value is (1)
the significance level of a = 0.01, (2)
the null hypothesis. There is (3)
evidence to support the claim that the percentage from the
ritonavir-boosted darunavir group is (4).
the percentage from the dorovirine group.
Analyze the results. Is dorovirine a more effective treatment for HIV-1 than ritonavir-boosted darunavir? Why or why not?
O A. Yes, since the decision of the test was to fail to reject the null hypothesis of the proportion from the ritonavir-boosted darunavir group being greater than the proportion of the dorovirine group.
O B. No, since the decision of the test was to fail to reject the null hypothesis of no difference.
OC. No; although the decision of the test was to reject the null hypothesis of no difference, it cannot be concluded that one treatment is better than the other-it can only be concluded that they are different.
O D. Yes, since the decision of the test was to reject the null hypothesis of no difference.
MacBook Pro
esc
G Search or type URL
@
#3
2$
%
&
2
3
4
7
8
9.
dele
LO
Expert Solution
![](/static/compass_v2/shared-icons/check-mark.png)
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 2 steps with 1 images
![Blurred answer](/static/compass_v2/solution-images/blurred-answer.jpg)
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, statistics and related others by exploring similar questions and additional content below.Recommended textbooks for you
![MATLAB: An Introduction with Applications](https://www.bartleby.com/isbn_cover_images/9781119256830/9781119256830_smallCoverImage.gif)
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
![Probability and Statistics for Engineering and th…](https://www.bartleby.com/isbn_cover_images/9781305251809/9781305251809_smallCoverImage.gif)
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
![Statistics for The Behavioral Sciences (MindTap C…](https://www.bartleby.com/isbn_cover_images/9781305504912/9781305504912_smallCoverImage.gif)
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
![MATLAB: An Introduction with Applications](https://www.bartleby.com/isbn_cover_images/9781119256830/9781119256830_smallCoverImage.gif)
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
![Probability and Statistics for Engineering and th…](https://www.bartleby.com/isbn_cover_images/9781305251809/9781305251809_smallCoverImage.gif)
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
![Statistics for The Behavioral Sciences (MindTap C…](https://www.bartleby.com/isbn_cover_images/9781305504912/9781305504912_smallCoverImage.gif)
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
![Elementary Statistics: Picturing the World (7th E…](https://www.bartleby.com/isbn_cover_images/9780134683416/9780134683416_smallCoverImage.gif)
Elementary Statistics: Picturing the World (7th E…
Statistics
ISBN:
9780134683416
Author:
Ron Larson, Betsy Farber
Publisher:
PEARSON
![The Basic Practice of Statistics](https://www.bartleby.com/isbn_cover_images/9781319042578/9781319042578_smallCoverImage.gif)
The Basic Practice of Statistics
Statistics
ISBN:
9781319042578
Author:
David S. Moore, William I. Notz, Michael A. Fligner
Publisher:
W. H. Freeman
![Introduction to the Practice of Statistics](https://www.bartleby.com/isbn_cover_images/9781319013387/9781319013387_smallCoverImage.gif)
Introduction to the Practice of Statistics
Statistics
ISBN:
9781319013387
Author:
David S. Moore, George P. McCabe, Bruce A. Craig
Publisher:
W. H. Freeman